Glioblastoma Multiforme (GBM):グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Glioblastoma Multiforme (GBM) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Glioblastoma Multiforme (GBM) 23
Subjects Recruited Over a Period of Time 32
Prominent Sponsors 33
Top Companies Participating in Glioblastoma Multiforme (GBM) Therapeutics Clinical Trials 35
Prominent Drug Comparison 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Merck & Co., Inc. 42
Clinical Trial Overview of Merck & Co., Inc. 42
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
AstraZeneca PLC 50
Clinical Trial Overview of AstraZeneca PLC 50
E. Merck KG 52
Clinical Trial Overview of E. Merck KG 52
Eli Lilly and Company 54
Clinical Trial Overview of Eli Lilly and Company 54
Eisai Co., Ltd. 55
Clinical Trial Overview of Eisai Co., Ltd. 55
Clinical Trial Overview of Top Institutes / Government 56
National Cancer Institute 56
Clinical Trial Overview of National Cancer Institute 56
Duke University 64
Clinical Trial Overview of Duke University 64
The University of Texas M. D. Anderson Cancer Center 67
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 67
Sidney Kimmel Comprehensive Cancer Center 69
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 69
Radiation Therapy Oncology Group 71
Clinical Trial Overview of Radiation Therapy Oncology Group 71
Dana-Farber Cancer Institute, Inc. 72
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 72
UCLA’s Jonsson Comprehensive Cancer Center 73
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 73
University of California, San Francisco 74
Clinical Trial Overview of University of California, San Francisco 74
Massachusetts General Hospital 75
Clinical Trial Overview of Massachusetts General Hospital 75
Weill Cornell Medical College 76
Clinical Trial Overview of Weill Cornell Medical College 76
Five Key Clinical Profiles 77
Appendix 110
Abbreviations 110
Definitions 110
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 114


【レポート販売概要】

■ タイトル:Glioblastoma Multiforme (GBM):グローバル臨床試験レビューH2, 2013
■ 英文:Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162857
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。